Study of TB flare-ups in people without HIV
Part of Immune system & allergy, Infections clinical trials.
This study looks at why some people with tuberculosis (TB) get worse or develop new inflammation after they initially start improving on treatment—called a “paradoxical reaction.” It collects blood and tissue samples to better understand these flare-ups and guide future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 or older.
- Have TB that is confirmed or strongly suspected, and you’re on TB medicine (ATT) or have finished it.
- If you’re in the flare-up group: you must have had at least 2 weeks of TB treatment and then developed signs of a TB flare after initial improvement (like symptoms coming back, new swollen glands, worse scans, or higher inflammation lab tests).
- In the control group: you must be 2 to 4 months after starting TB treatment, without the flare-up pattern being the focus.
- You cannot have HIV infection.
- Be willing to provide blood or tissue samples for future research and be able to give informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with suspected or confirmed tuberculosis (TB), whether they have inactive “latent” TB or active TB. It helps researchers better understand TB’s natural course and may improve future testing and care by allowing collection and storage of samples.
This study looks at how the immune system reacts in people with tuberculosis (TB), their close contacts, people with other lung diseases, and healthy volunteers. It aims to find better ways to diagnose and manage TB.
This study looks at immune system blood tests in adults being treated for active tuberculosis and/or latent tuberculosis infection. The goal is to see if these “immune biomarkers” can help guide or improve tuberculosis management.
This study tests different treatment plans for people with tuberculosis (TB) that can be cured with standard medicines. It aims to find the best treatment for each person based on their risk score, which may lead to shorter or more effective treatment.
This study tests new, faster ways to detect tuberculosis (TB) using phlegm, tongue swabs, or urine. It aims to find a simpler and more accurate test than current ones, which could help you get the right treatment sooner.
This study tests rapid TB screening and lab-style diagnostic methods to see how well they find TB disease and TB that is resistant to rifampin (a key TB drug). It may help doctors diagnose TB faster and more accurately, especially in people at higher risk.
Hear when a new Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.